|
WO2021023143A1
|
|
Method for preparing pharmaceutical intermediate of relugolix
|
|
WO2020147852A1
|
|
Crystal forms of antidepressant drug sage-217 and preparation method therefor
|
|
WO2020043033A2
|
|
Synthesis methods for upadacitinib and intermediate thereof
|
|
CN111909160A
|
|
Upacatinib salt compound and preparation method thereof
|
|
CN111689907A
|
|
Crystal form A of intermediate of elogolide and sodium salt thereof, preparation method and application
|
|
CN109651171A
|
|
The preparation method and application of the intermediate and its salt of Yi Lageli and its sodium salt
|
|
US2020354368A1
|
|
Processes to produce acalabrutinib
|
|
CN110938037A
|
|
Preparation method of drug intermediate of Eragoli sodium salt
|
|
CN110903254A
|
|
Synthetic method of heterocyclic intermediate applied to JAK inhibitor drugs
|
|
CN110872250A
|
|
Two compounds, preparation methods thereof and application thereof in synthesis of ursitinib
|
|
CN110835302A
|
|
Intermediate of oxaagolide and sodium salt thereof and preparation method thereof
|
|
CN110818705A
|
|
Salt form and corresponding crystal form of valine benazidine and preparation method thereof
|
|
CN110818722A
|
|
Three compounds, preparation method thereof and application thereof in synthesizing suogliflozin
|
|
CN110128355A
|
|
A kind of preparation method containing 6- methyluracil structural compounds
|
|
CN109956872A
|
|
A kind of preparation method of 4- cyclopropyl-naphthalidine
|
|
CN109867631A
|
|
A kind of preparation method containing 6- methyluracil structural compounds
|
|
CN109836316A
|
|
A kind of synthetic method of 3,3- dimethylcyclohexanon
|
|
CN109836416A
|
|
A kind of preparation method of compound
|
|
JOP20170186A1
|
|
Processes to produce brivaracetam
|
|
CN109748929A
|
|
A kind of preparation method of compound
|
